Form 4 for AGEN AGENUS INC
Accepted 2025-06-30 00:00:00 ET · period of report 2025-06-18 · accession 0000950170-25-091630 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 2025-06-18 | AGEN | O'Day Steven J | Chief Medical Off | A - Grant | $4.47 | +43.5K | 57.1K | +319% | +$194.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-18 | A | A | 43,497 | $4.47 | 57,116 | D | — | — | (F1) Reflects the executive's 2024 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 30-day lockup restriction with 100% of the award released on July 18, 2025. (F2) $4.47 is the closing price of our Common Stock on June 18, 2025, the stock issuance date. |